News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Clinical - Approvals
Novo Nordisk A/S (NVO) Receives FDA Approval For Norditropin® Flexpro® 30 Mg/3.0 Ml For Patients With Growth Hormone Disorders 1/27/2015
Moberg Pharma AB (Formerly known as Moberg Derma)'s Fungal Nail Product Approved In China 1/27/2015
FDA Backs Teva Pharmaceutical Industries Limited (TEVA)'s Generic Nexium in Blow to AstraZeneca PLC (AZN), Ranbaxy Laboratories (RANBAXY.BO) 1/27/2015
Shire (SHPGY)'s $5.2 Billion Bet Pays Off as NPS Pharmaceuticals, Inc. (NPSP)'s Natpara Wins Approval 1/27/2015
FDA Says Yes to Rockwell Medical (RMTI)'s Iron Replacement Drug 1/27/2015
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Approves Natpara® (Parathyroid Hormone) For Injection As An Adjunct To Calcium And Vitamin D To Control Hypocalcemia In Patients With Hypoparathyroidism 1/26/2015
Novartis AG (NVS) Bexsero® Vaccine Approved By FDA For The Prevention Of Meningitis B, The Leading Cause Of Bacterial Meningitis In The US 1/26/2015
Shire Comments On Press Release From FDA Regarding NPS Pharmaceuticals, Inc. (NPSP) Approval Of NATPARA® (Parathyroid Hormone) 1/26/2015
The National Meningitis Association (NMA) Applauds FDA Approval Of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 1/26/2015
FDA Approves Rockwell Medical (RMTI)l's Triferic™ For Iron Replacement And Maintenance Of Hemoglobin In Hemodialysis Patient 1/26/2015
Symplmed Announces FDA Approval of Prestalia® for Treatment of Hypertension 1/26/2015
FDA Approves Novartis AG (NVS)'s Cosentyx for Painful Skin Disease 1/23/2015
Incyte Corporation (INCY) Earns $25 Million Milestone As Jakavi® (ruxolitinib) Recommended For Approval In Europe For Polycythemia Vera 1/23/2015
Novartis AG (NVS) Announces FDA Approval For First IL-17A Antagonist Cosentyx™ (Secukinumab) For Moderate-To-Severe Plaque Psoriasis Patients 1/22/2015
Marrone Bio Innovations, Inc' REGALIA® MAXX Biofungicide Approved For New Uses In Canada 1/22/2015
Akorn, Inc. (AKN) Receives FDA Approval For Phenylephrine HCl Ophthalmic Solution 1/20/2015
Baxter International, Inc. (BAX) Receives FDA Approval For PHOXILLUM Solution For Electrolyte Management During Continuous Renal Replacement Therapy 1/20/2015
China Approves World's First Inactive Sabin Strain Polio Vaccine 1/20/2015
Fresenius Kabi AG Receives FDA Approval For Neostigmine Methylsulfate Injection 1/19/2015
Boehringer Ingelheim Corporation Release: OFEV® (Nintedanib*) Approved In The EU For The Treatment Of IPF 1/19/2015
AbbVie (ABBV) Announces U.S. FDA Approval Of DUOPA™ (carbidopa and levodopa) Enteral Suspension For The Treatment Of Motor Fluctuations In Patients With Advanced Parkinson's Disease 1/16/2015
CeloNova BioSciences Receives Expanded Indication For Benign Prostatic Hyperplasia (BPH) 1/14/2015
AbbVie (ABBV) Announces U.S. FDA Approval Of DUOPA™ (carbidopa and levodopa) Enteral Suspension For The Treatment Of Motor Fluctuations In Patients With Advanced Parkinson's Disease 1/12/2015
HUYA Bioscience International Announces Regulatory Approval Of Chidamide, The First Selective HDAC Inhibitor In China 1/12/2015
U.S. FDA Approves Daiichi Sankyo, Inc. (4568.t)'s Once-Daily SAVAYSA™ (Edoxaban) Tablets For Reduction Of Stroke Risk In Non-Valvular Atrial Fibrillation And For The Treatment Of Venous Thromboembolism 1/9/2015
FDA Green Lights Daiichi Sankyo, Inc. (4568.t)'s New Anti-Clotting Drug 1/9/2015
Impax Pharmaceuticals (IPXL) Announce FDA Approval Of RYTARY™ (Carbidopa And Levodopa) Extended-Release Capsules For The Treatment Of Parkinson's Disease 1/8/2015
Lyophilization Services of New England Receives Approval To Manufacture Commercial Aseptic Product 1/7/2015
Suneva Medical Release: Bellafill® Receives FDA Approval For Treatment Of Acne Scars 1/6/2015
Actavis (ACT), Adamas Pharmaceuticals (ADMS) Win FDA Approval for Alzheimer's Drug Namzaric 1/5/2015
Vertex Pharmaceuticals (MA) (VRTX) Release: FDA Approves KALYDECO® (Ivacaftor) For Use In People With Cystic Fibrosis Ages 6 And Older Who Have The R117H Mutation 12/30/2014
FDA Denies Approval for Actavis (ACT)' Hypertension Combo Treatment 12/30/2014
Hospira, Inc. Receives U.S. FDA Approval Of Proprietary Analgesic Dyloject™(diclofenac sodium) Injection 12/30/2014
Actavis (ACT) Confirms Complete Response Letter For Nebivolol/Valsartan Fixed-Dose Combination For Hypertension 12/29/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces Approval Of VIMIZIM® (Elosulfase Alfa) In Japan For Treatment Of Morquio A Syndrome 12/29/2014
FDA Approves Novo Nordisk A/S (NVO)'s Weight Management Drug Saxenda 12/29/2014
Novo Nordisk A/S (NVO) Receives FDA Approval For Saxenda® For The Treatment Of Obesity 12/24/2014
AstraZeneca PLC (AZN) Grabs Accelerated FDA Approval for Lynparza 12/24/2014
FDA Grants Accelerated Approval for Bristol-Myers Squibb Company (BMY)'s Skin Cancer Drug Opdivo 12/24/2014
Actavis (ACT) and Adamas Pharmaceuticals (ADMS) Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride 12/24/2014
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)’s GRANIX® (Tbo-Filgrastim) Injection For Self-Administration 12/23/2014
Galderma Laboratories Receives FDA Approval Of Novel Treatment Option For Rosacea Patients 12/23/2014
Bristol-Myers Squibb Company (BMY) Receives Accelerated Approval Of Opdivo (Nivolumab) From The FDA 12/23/2014
AbbVie (ABBV) Receives Health Canada Approval Of HOLKIRA™ PAK For The Treatment Of Chronic Genotype 1 Hepatitis C 12/23/2014
FDA Approves Biocryst Pharmaceuticals (BCRX)'s Intravenous Flu Drug Rapivab 12/22/2014
FDA Approves AbbVie (ABBV)'s All-Oral Hepatitis C Drug Viekira Pak 12/22/2014
AbbVie (ABBV) Receives U.S. FDA Approval Of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) For The Treatment Of Chronic Genotype 1 Hepatitis C 12/22/2014
Biocryst Pharmaceuticals (BCRX)'s RAPIVAB™ (Peramivir Injection) Receives FDA Approval For The Treatment Of Acute Uncomplicated Influenza 12/22/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014
AstraZeneca PLC (AZN) Release: LYNPARZA™ Approved By The FDA For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-Mutations 12/22/2014
LYNPARZA™ (Olaparib) Approved For The Treatment Of Advanced Relapsed Ovarian Cancer In Patients With Germline BRCA Mutations, Available Exclusively At Biologics, Inc. (NC) 12/22/2014
Cubist Pharmaceuticals, Inc. (CBST) Announces FDA Approval Of New Antibiotic ZERBAXA™ (Ceftolozane/Tazobactam) For Complicated Urinary Tract And Complicated Intra-abdominal Infections 12/22/2014
Enanta Pharmaceuticals, Inc. Announces FDA Approves AbbVie (ABBV)’s VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) For The Treatment Of Chronic Genotype 1 Hepatitis C Virus 12/22/2014
Alcon Laboratories, Inc. (ACL) Release: FDA Approves Xtoro To Treat Swimmer's Ear 12/19/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval Of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol For Treatment Of Children With Seasonal And Perennial Allergic Rhinitis 12/19/2014
Eli Lilly (LLY)'s CYRAMZA (ramucirumab) Receives Third FDA Approval 12/18/2014
FDA Approves Novartis AG (NVS) Drug For Rare Hormonal Disorder 12/17/2014
Allaccem, Inc. Receives Formulary Approval For SANOS® From The Veterinary Medical Standardization Board Of The US Army Public Health Command 12/17/2014
Ipsen (IPN.PA) Announces FDA Approval Of Somatuline® Depot® (Lanreotide) Injection For The Treatment Of Gastroenteropancreatic Neuroendocrine Tumors 12/17/2014
Novartis AG (NVS) Gains FDA Approval For Signifor® LAR To Treat Patients With Acromegaly, A Rare And Life-Threatening Hormonal Disorder 12/16/2014
Sanofi Pasteur (SASY.PA) Announces FDA Approval Of Fluzone Intradermal Quadrivalent (Influenza Vaccine) For Adults 12/12/2014
Orexo AB (ORXOF): FDA Approves Two Higher Dosage Strengths Of ZUBSOLV® 12/12/2014
FDA Approves Merck & Co. (MRK)'s HPV Vaccine, GARDASIL®9, To Prevent Cancers And Other Diseases Caused By Nine HPV Types – Including Types That Cause About 90% Of Cervical Cancer Cases 12/12/2014
BioMarin Pharmaceutical Inc. (BMRN)'s VIMIZIM® (Elosulfase Alfa) Approved In Brazil For Treatment Of Morquio A Syndrome 12/10/2014
Iroko Pharmaceuticals Announces International Regulatory Approval For ZORVOLEX® 12/10/2014
Nektar Therapeutics (CA) (NKTR) Release: MOVENTIG Approved In The European Union For Opioid-Induced Constipation 12/9/2014
Amgen (AMGN) Wins FDA Approval For New XGEVA Indication 12/9/2014
FDA Approves Amgen (AMGN)'s XGEVA (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy 12/8/2014
BioMarin Pharmaceutical Inc. (BMRN)''s VIMIZIM® (Elosulfase Alfa) Approved In Australia For Treatment Of Morquio A Syndrome 12/8/2014
Merz Dermatology Announces Approval Of Naftin (Naftifine HCL) Gel And Cream 2% For Use With Pediatric Patients 12/8/2014
WraSer Pharmaceuticals, LLC Receives FDA Approval On Trezix Capsules, CIII For Moderate To Moderately Severe Pain 12/5/2014
FDA Approves Incyte Corporation (INCY)'s Jakafi For Patients With Polycythemia Vera 12/5/2014
Speedy FDA Approval For Amgen (AMGN)'s Leukemia Immunotherapy BLINCYTO 12/5/2014
National Institute for Clinical Excellence (NICE) Reverses October Decision And Approves Roche (RHHBY)'s Oncology Drug Gazyvaro 12/3/2014
Astellas Pharma US Release: XTANDI™ (Enzalutamide) Now Approved In Europe For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer Who Are Chemotherapy-Naïve 12/2/2014
pSivida Corp (PSDV) Reports ILUVIEN® Granted Marketing Authorization In The Netherlands 12/2/2014
Perrigo Company (PRGO) Announces FDA Approval And Launch Of The Generic Version Of Pennsaid 1.5% W/W 12/2/2014
Sanofi (SAN.PA) Gets U.S. Approval For Use Of Priftin Drug In Latent TB 12/2/2014
Bayer Receives Health Canada Approval for Eylea For Two Additional Indications 12/1/2014
Once-Weekly Eli Lilly (LLY) Diabetes Drug Wins FDA Approval 11/26/2014
FDA Approves Valeant (VRX)'s Onexton Gel For Acne Treatment 11/26/2014
Bristol-Myers Squibb Company (BMY) Release: ELIQUIS Approved For Treatment Of Venous thromboembolic events (Deep Vein Thrombosis [DVT], Pulmonary Embolism [PE]) and prevention of recurrent DVT and PE 11/26/2014
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s Rezolsta 11/25/2014
Ariad Pharmaceuticals, Inc. (ARIA) And Specialised Therapeutics Australia Announce Approval Of Iclusig (Ponatinib) In Australia 11/24/2014
Purdue Pharma L.P. Wins FDA Approval For Powerful Painkiller Hysingla 11/24/2014
Health Canada Approves IMBRUVICA By Priority Review, Giving Physicians And Patients A Much-Needed Option In The Fight Against Chronic Lymphocytic Leukemia 11/19/2014
Celgene (CELG) Announces Swissmedic Approval Of REVLIMID® (Lenalidomide) For Treatment Of Patients With Relapsed Or Refractory 11/18/2014
Regeneron (REGN) Announces EYLEA (aflibercept) Injection Approved For The Treatment Of Diabetic Macular Edema (DME) In Japan 11/18/2014
Regeneron (REGN)'s Eylea Gets Japanese Nod For Macular Edema 11/18/2014
(Pr)OTEZLA® (apremilast tablets), First In A New Class Of Oral Treatment, Receives Health Canada Approval For Plaque Psoriasis 11/18/2014
FDA Approves Genentech (RHHBY)’s Avastin (Bevacizumab) Plus Chemotherapy To Treat Women With Platinum-Resistant Recurrent Ovarian Cancer 11/17/2014
FDA Approves Genzyme Corporation (GENZ)’s Lemtrada For MS 11/17/2014
FDA Approves Roche (RHHBY)’s Avastin Plus Chemotherapy To Treat Women With Platinumresistant Recurrent Ovarian Cancer 11/17/2014
pSivida Corp (PSDV) Reports ILUVIEN® Granted Marketing Authorization In Belgium 11/12/2014
Par Pharmaceutical, Inc. Announces First FDA Approval Of Vasostrict™ (Vasopressin Injection, USP) 11/12/2014
Endo Pharmaceuticals (ENDP) Receives Final Approval For Generic Version Of Valcyte® 11/10/2014
Dr. Reddy's Laboratories Ltd. (RDY) Wins FDA Approval For Roche (RHHBY) Drug Generic 11/7/2014
Eli Lilly (LLY)'s CYRAMZA® (ramucirumab) in Combination with Paclitaxel Granted FDA Approval for Advanced Gastric Cancer After Prior Chemotherap 11/6/2014
Ipsen (IPN.PA) Announces FDA Approval Of A New Delivery Device For Somatuline® Depot® (Lanreotide) Injection 11/6/2014
Eli Lilly (LLY) Wins FDA Approval For Gastric Cancer Combination Drug 11/6/2014
Johnson & Johnson (JNJ), Medivir AB (MVRBF) Snags U.S. Approval For Hepatitis C Combo With Gilead Sciences, Inc. (GILD) 11/6/2014
Glenmark Generics Receives Final ANDA Approval For Omeprazole DR Capsules 11/5/2014
Ranbaxy Laboratories (RANBAXY.BO) Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg 11/5/2014
Vectura Group plc (VEC.L) Approval In Baltics For Innovative Respiratory Inhaler AirFluSal® Forspiro® 11/4/2014
Sanofi Pasteur (SASY.PA) Announces FDA Approval Of Updated Prescribing Information For Fluzone® High-Dose Vaccine For Adults 65 And Older 11/3/2014
Breckenridge Pharmaceutical, Inc. Announces Approval Of QUETIAPINE FUMARATE TABLETS 11/3/2014
Admedus Cardiocel® Gains Special Access In Singapore 11/3/2014
FDA Panel Backs Daiichi Sankyo, Inc. (4568.t)'s New A-Fib Drug Savaysa 10/31/2014
AstraZeneca PLC (AZN) Wins FDA Approval For Two-In-One Diabetes Pill 10/31/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Approved For Adults Ages 18 And Older 10/30/2014
TWi Pharmaceuticals, Inc. Receives U.S. FDA Approval On Generic Donepezil Hydrochloride Tablets USP, 23 Mg, Its Fifth ANDA From U.S. FDA 10/30/2014
Lannett Company, Inc. (LCI) Receives FDA Approval For Letrozole Tablets USP 2.5 mg 10/30/2014
Pfizer (PFE) Wins FDA Accelerated Approval For Meningitis Vaccine 10/30/2014
Europe Approves Clinuvel's Novel Australian Drug Developed For Rare Sun Disease 10/24/2014
AstraZeneca PLC (AZN)'s Cancer Drug Pipeline Gets Boost From European Green Light 10/24/2014
Baxter International, Inc. (BAX)'s Hemophilia A Drug Obizur Wins FDA Approval 10/24/2014
FDA Release: Gilead Sciences, Inc. (GILD)'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute 10/23/2014
Santen Announces Positive Outcome Of The European Decentralized Procedure For Approval Of TAPTIQOM® 10/22/2014
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval 10/22/2014
Vertex Pharmaceuticals (MA) (VRTX) Surges As FDA Advisory Panel Approves Kalydeco's Label Expansion 10/22/2014
Auxilium Pharmaceuticals (AUXL) Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients 10/21/2014
BioSpecifics Technologies Corporation (BSTC) Announces FDA Approval Of sBLA For XIAFLEX® For The Concurrent Treatment Of Two Dupuytren's Contracture Cords 10/21/2014
Halozyme Therapeutics, Inc. (HALO) Receives FDA Approval For Additional Manufacturing Facilities For Hylenex® Recombinant 10/20/2014
Pfizer (PFE) Release: FDA Approves Abuse Deterrent Labeling For EMBEDA® (morphine sulfate and naltrexone hydrochloride) Extended-Release (ER) Capsules CII 10/20/2014
China Biologic Products Awarded CFDA Approval To Manufacture Plasma Product 10/20/2014
InterMune, Inc. (ITMN) Wins FDA Approval For Lung Drug At Center Of Roche (RHHBY) Deal 10/17/2014
Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev 10/17/2014
FDA Approves Gilead Sciences, Inc. (GILD)'s New Hepatitis C Drug Harvoni 10/15/2014
FDA Approves Expanded Use Of Navidea Biopharmaceuticals (NAVB)’s Lymphoseek® For Lymphatic Mapping In Solid Tumors 10/15/2014
ViiV Healthcare Receives Approval For Triumeq™ (dolutegravir/abacavir/lamivudine), In Canada - A New Once-Daily Single-Pill Regimen For The Treatment Of HIV 10/14/2014
Eisai Inc. (ESALF.PK) Grabs FDA Approval For Chemotherapy Side Effect Drug AKYNZEO® 10/13/2014
Sunascen Therapeutics Gets FDA's Green Light For The New Over The Counter NAUS-EASE® Tablets 10/10/2014
FDA Approves Eisai Inc. (ESALF.PK) Drug For Chemotherapy-Associated Nausea 10/10/2014
Millennium: The Takeda Oncology Company Release: FDA Approves VELCADE® (Bortezomib) For Injection For Previously Untreated Patients With Mantle Cell Lymphoma 10/9/2014
Salix Pharmaceuticals, Ltd. (SLXP) Release: FDA Approves UCERIS® (Budesonide) 2mg Rectal Foam For The Induction Of Remission Of Mild-To-Moderate Distal Ulcerative Colitis 10/8/2014
Novartis AG (NVS) Release: (Pr)Lucentis® (ranibizumab) Approved By Health Canada To Treat Vision Loss Resulting From Choroidal Neovascularization In Pathologic Myopia (mCNV)(1) 10/8/2014
Ferring Pharmaceuticals Receives FDA Approval For New Cranberry Flavor Of PREPOPIK® (Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid) 10/7/2014
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Injection Receives FDA Approval For Macular Edema Following Retinal Vein Occlusion (RVO) 10/7/2014
AbbVie (ABBV)'s HUMIRA® (adalimumab) Receives U.S. FDA Approval For Extension Of Polyarticular Juvenile Idiopathic Arthritis Indication To Patients Ages 2 And Older 10/6/2014
Ganeden Biotech Release: GanedenBC30 Probiotic Approved In Japan, Taiwan, India & Philippines 10/6/2014
Diplomat Release: XTANDI® (enzalutamide) Receives Expanded Approval From FDA For Treatment Of Metastatic Castration-Resistant Prostate Cancer 10/1/2014
U.S. FDA Approves Dual-Chamber Syringe For Abilify Maintena® (Aripiprazole) Extended-Release Injectable Suspension For The Treatment Of Schizophrenia 9/30/2014
Cesca Therapeutics Announces Approval Of Its AXP ® Autoxpress ® System In Taiwan 9/29/2014
Allergan Inc. (AGN) Announces FDA Approves Revised Indication For OZURDEX ® (Dexamethasone Intravitreal Implant) 0.7 Mg For The Treatment Of Diabetic Macular Edema 9/29/2014
Alimera Sciences (ALIM), pSivida Corp (PSDV) Eye Implant Finally Wins FDA Approval 9/29/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Announces FDA Approval Of Spiriva® Respimat® (Tiotropium Bromide) Inhalation Spray For The Maintenance Treatment Of COPD 9/25/2014
AbbVie (ABBV)'s HUMIRA® (adalimumab) Receives U.S. FDA Approval For The Treatment Of Pediatric Patients With Moderately To Severely Active Crohn's Disease 9/25/2014
Celgene (CELG) Announces The Swissmedic Approval Of ABRAXANE® For Treatment Of Both Metastatic Pancreatic And Breast Cancers 9/25/2014
Celgene (CELG)'s Psoriasis Drug Wins Approval For New Indication 9/24/2014
Noven Pharmaceuticals Inc. Receives FDA Approval Of A New Indication With A New Dose For Minivelle® (Estradiol Transdermal System) 9/24/2014
Eli Lilly and Company (LLY) Gets Thumbs Up From FDA For Diabetes Drug Trulicity 9/22/2014
Auxilium Pharmaceuticals (AUXL), VIVUS, Inc. (VVUS)'s Faster-Acting Erectile Dysfunction Drug Wins FDA Approval 9/19/2014
FDA Approves AstraZeneca PLC (AZN), Nektar Therapeutics (CA) (NKTR)'s MOVANTIK™ For Opioid-Induced Constipation 9/16/2014
EPIRUS’ Remicade® Biosimilar Receives Final Approvals In India 9/16/2014
FDA Approves Baxter International, Inc. (BAX), Halozyme Therapeutics, Inc. (HALO)'s HYQVIA 9/15/2014
FDA Approves Orexigen Therapeutics, Inc. (OREX)'s Long-Awaited Weight Loss Drug Contrave 9/12/2014
Lannett Company, Inc. (LCI) Receives FDA Approval For Oxycodone Hydrochloride Oral Solution USP, 100 mg Per 5 mL 9/11/2014
FDA Approves Keryx Biopharmaceuticals (KERX)' Kidney Drug Ferric Citrate With Warnings, Shares Crash 9/9/2014
ThromboGenics NV (TBGNF)' JETREA® Gains Approval In South Korea 9/8/2014
FDA Approves Merck & Co. (MRK)'s New-Kind Of Cancer Drug Keytruda 9/8/2014
DS Healthcare Group Obtains Regulatory Approval In Middle East 9/4/2014
China’s Food And Drug Administration Has Cleared NovaBay Pharmaceuticals, Inc. (NBY)’s Neutrophase Skin And Wound Cleanser For Sale Throughout Mainland China By NovoBay’s Partner, China Pioneer Pharma 9/3/2014
Allergan Inc. (AGN) Announces OZURDEX® (Dexamethasone 700 Mcg Intravitreal Implant In Applicator) Now Approved In The European Union For The Treatment Of Diabetic Macular Edema 9/2/2014
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures 9/2/2014
GE Healthcare Announces European Union Approval Of VIZAMYL™ (Flutemetamol (18F) Solution For Injection) For PET Imaging Of Beta Amyloid Plaque In Suspected Alzheimer’s Disease 9/2/2014
INNOPHARMA Announces FDA Approval Of Decitabine For Injection, A Generic Version Of DACOGEN® 8/29/2014
Pfizer Inc. (PFE) And FDA Announce Protalix Biotherapeutics, Inc. (PLX) Approval Of Pediatric Indication For ELELYSO™ (taliglucerase alfa) For Injection, For Intravenous Use For The Treatment Of Type 1 Gaucher Disease 8/29/2014
TWi Pharmaceuticals, Inc. Receives FDA Final Approval On Generic Megestrol Acetate 125mg/Ml Oral Suspension 8/28/2014
SciClone Pharmaceuticals, Inc. (SCLN) And BTG plc (BTG.L) Announce That DC Bead® Has Been Approved By China Food And Drug Administration 8/28/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: Health Canada Approves Eloctate™, The First Therapy To Extend The Interval Between Prophylactic Infusions In Hemophilia A 8/26/2014
Fresenius Kabi AG Receives FDA Approval For Kabiven® And Perikabiven® 8/26/2014
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE)'s ViiV Healthcare Wins Approval For HIV Combo Drug 8/25/2014
Iroko Pharmaceuticals Gains FDA Approval Of ZORVOLEX® For Management Of Osteoarthritis Pain 8/25/2014
GlaxoSmithKline (GSK) Receives FDA Approval Of An Additional Promacta® (Eltrombopag) Indication For Use In Patients With Severe Aplastic Anaemia (SAA) Who Have Had An Insufficient Response To Immunosuppressive Therapy (IST) 8/25/2014
Mylan Inc. (MYL) Launches First Generic Klor-Con® Extended-Release Tablets 8/22/2014
FDA Approves Use Of Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE)'s Eliquis To Treat Leg, Lung Clots 8/22/2014
GlaxoSmithKline (GSK)'s Asthma Treatment Wins FDA Approval 8/21/2014
Amerigen Pharmaceuticals Announces That Its Chinese Subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., Has Received Chinese FDA (CFDA) Approval And Has Subsequently Launched Its Generic Mecobalamin 0.5 Mg Tablets Into The China Domestic Market 8/20/2014
FDA Approves Genzyme Corporation (GENZ)'s Gaucher Disease Pill Cerdelga 8/20/2014
FDA Approves Biogen Idec, Inc. (Massachusetts) (BIIB)'s Multiple Sclerosis Drug Plegridy 8/19/2014
Merck & Co. (MRK) Wins FDA Approval For New Type Of Sleeping Pill 8/15/2014
Genentech (RHHBY) Wins Approval To Treat Advanced Cervical Cancer 8/15/2014
B.Braun Medical Receives FDA Approval For Nutrilipid® 20% 8/13/2014
Millennium: The Takeda Oncology Company Release: FDA Approves VELCADE® (Bortezomib) Retreatment In Patients With Multiple Myeloma 8/11/2014
FDA Green Lights Johnson & Johnson (JNJ)'s Diabetes Drug Invokamet 8/11/2014
FDA Approves The Medicines Company (MDCO)'s Acute Skin Infection Drug Orbactiv 8/7/2014
NanoString Technologies Inc. (NSTG) Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 8/6/2014
Health Canada Approves Celgene Corporation (CELG)'s ABRAXANE® Plus Gemcitabine For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 8/6/2014
European Commission (EC) Approves Roche (RHHBY)’s Avastin For Platinum-Resistant Recurrent Ovarian Cancer 8/6/2014
FDA Approves Baxter International, Inc. (BAX)’s FLEXBUMIN 5%, First And Only 5% Human Albumin Solution In A Flexible Container 8/4/2014
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients 8/1/2014
FDA Green Lights Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Jardiance For Type 2 Diabetes 8/1/2014
Vertex Pharmaceuticals Incorporated (VRTX) Receives European Approval For KALYDECO™ (ivacaftor) In Eight Non-G551D Gating Mutations 8/1/2014
Regeneron Pharmaceuticals, Inc. (REGN) Release: EYLEA® (aflibercept) Injection Receives FDA Approval For The Treatment Of Diabetic Macular Edema (DME) 7/31/2014
Roche (RHHBY)’s Gazyvaro Approved In Europe For Patients With The Most Common Type Of Leukemia 7/29/2014
Bristol-Myers Squibb Company (BMY) Release: European Commission Approves Eliquis (Apixaban) For The Treatment Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE), And Prevention Of Recurrent DVT And PE 7/29/2014
U.S. FDA Grants Regular (Full) Approval For Pharmacyclics, Inc. (PCYC)'s IMBRUVICA® For Two Indications 7/28/2014
Aqua Pharmaceuticals Announces FDA Approval Of ACTICLATE™ (Doxycycline Hyclate USP) Tablets, 150 Mg And 75 Mg 7/28/2014
FDA Approves Purdue Pharma L.P.’s Hard-to-Abuse Narcotic Painkiller 7/28/2014
FDA Approves Gilead Sciences, Inc. (GILD)'s Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma 7/23/2014



//-->